Skip to main content
Clinical Trials/NL-OMON37433
NL-OMON37433
Completed
Not Applicable

Optimizing orthotic management in children with cerebral palsy to improve mobility and participation - AFO efficacy in Cerebral Palsy

Vrije Universiteit Medisch Centrum0 sites32 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
brain damage
Sponsor
Vrije Universiteit Medisch Centrum
Enrollment
32
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • \- children diagnosed with spastic Cerebral Palsy
  • \- children aged between 6 and 14 years
  • \- a gait pattern that is characterized by excessive knee flexion
  • \- Gross motor function classification score (GMFCS) I \- III, provided that the patient is able perform a 3D\-gait analysis without walking aids
  • \- ability to walk independently for at least five minutes at a comfortable walking speed (CWS).

Exclusion Criteria

  • \- orthopaedic surgery or other surgical interventions that might influence mobility in the past 6 months
  • \- Botulinum Toxin A injections in the past three months
  • \- intrathecal Baclofen (ICB) therapy in the last six months or selective dorsal rhizotomy (SDR) in the past year
  • \- impairments that contra indicate fitness tests
  • \- severe joint contractures
  • \- severe behavioural problems

Outcomes

Primary Outcomes

Not specified

Similar Trials